Ana Flávia da Silva Amorim

Ana Flávia da Silva Amorim

Auto-generated profile, based on publicly available information

Ana Flávia da Silva Amorim

Department of Food and Drugs, Faculty of Pharmaceutical Sciences, Federal University of Alfenas, Alfenas, Brazil

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 July 2024 in Naunyn-Schmiedeberg's Archives of Pharmacology
Verified
Journal Article
Closed access
PDF file
AAAna Flávia da Silva Amorim
Ana Flávia da Silva Amorim
JSJoselin Valeska Martinez Sobalvarro
Joselin Valeska Martinez Sobalvarro
LTLarissa Helena Torres
Larissa Helena Torres
TRTiago Marques Reis
Tiago Marques Reis

15 July 2023 in Journal of Pharmaceutical and Biological Sciences
Verified
Journal Article
Open access
PDF file
ASAlessandra Oliveira Silva
Alessandra Oliveira Silva
DMDanielle Aparecida de Oliveira Marrafon
Danielle Aparecida de Oliveira Marrafon
AAAna Flávia Amorim
Ana Flávia Amorim
CBCarlos Marcelo de Barros
Carlos Marcelo de Barros
RRRicardo Radighieri Rascado
Ricardo Radighieri Rascado
MPMarilia Gabriella Alves Goulart Pereira
Marilia Gabriella Alves Goulart Pereira
Chronic pain affects approximately 30 % of the world population. Tapentadol can be an analgesic option for patients who do not respond adequately to commonly used opioids. This study reviewed the general aspects of Tapentadol pain treatment and its possible association with increased oxidative stress, as well as the benefits of its association with antioxidant substances. The search was carried out in the Medline (Pubmed), Scopus, Web of Science, and Google academic databases, including studies since the registration of the drug in 2008. The selected articles were those related to the use of Tapentadol for chronic moderate to severe pain, but not cancer-related pain, in adults and the elderly. Tapentadol is a µ opioid receptors agonist and inhibits noradrenaline reuptake. Although Tapentadol causes fewer adverse effects than other conventional opioids, studies have shown the induction of oxidative stress by this drug, but without having elucidated the mechanisms.